Stock KOBO KOBO BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Kobo Biotech Limited

Equities

KOBO

INE881A01015

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 11:00:56 28/06/2024 BST 		5-day change 1st Jan Change
3.8 INR -4.52% Intraday chart for Kobo Biotech Limited -9.95% +22.58%
07:46am Kobo Biotech Limited Announces Resignation of Jignesh Patel as Company Secretary and Compliance Officer CI
05-30 Kobo Biotech Limited Announces Resignation of Abhishek Buddhadev as Non-Executive and Independent Director CI

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 223 109.6 68.85 176.3 131 45.27
Enterprise Value (EV) 1 2,441 2,472 2,575 2,766 1,537 1,442
P/E ratio -0.94 x -0.45 x -0.33 x -0.92 x -0.86 x -0.82 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -79.2 x -82.6 x -98.8 x -125 x -11.4 x -151 x
EV / FCF -45.3 x -53.1 x -33.4 x -368 x 1.57 x 43.8 x
FCF Yield -2.21% -1.88% -2.99% -0.27% 63.5% 2.28%
Price to Book -0.53 x -0.16 x -0.08 x -0.16 x -0.11 x -0.04 x
Nbr of stocks (in thousands) 23,725 23,825 23,825 23,825 23,825 23,825
Reference price 2 9.400 4.600 2.890 7.400 5.500 1.900
Announcement Date 30/05/18 06/09/19 07/12/20 08/11/21 08/09/22 09/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA 1 -30.83 -29.94 -26.08 -22.06 -134.5 -9.538
EBIT 1 -95.28 -91.4 -84.86 -78.43 -178.8 -50.18
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -239.2 -244.6 -210.1 -192.3 -152.3 -55.53
Net income 1 -239.2 -244.6 -210.1 -192.3 -152.3 -55.53
Net margin - - - - - -
EPS 2 -10.04 -10.27 -8.820 -8.070 -6.391 -2.331
Free Cash Flow 1 -53.93 -46.54 -76.99 -7.521 975.9 32.92
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 30/05/18 06/09/19 07/12/20 08/11/21 08/09/22 09/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 2,218 2,362 2,506 2,590 1,406 1,397
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -71.96 x -78.9 x -96.11 x -117.4 x -10.45 x -146.5 x
Free Cash Flow 1 -53.9 -46.5 -77 -7.52 976 32.9
ROE (net income / shareholders' equity) 78.3% 44.7% 27.1% 19.7% 13.3% 4.44%
ROA (Net income/ Total Assets) -2.39% -2.35% -2.23% -2.1% -7.21% -4.06%
Assets 1 10,007 10,392 9,422 9,159 2,110 1,368
Book Value Per Share 2 -17.80 -28.10 -36.90 -45.00 -51.40 -53.70
Cash Flow per Share 2 0.0400 0.0400 0.0400 0.6400 0.0400 0.0400
Capex - 0.04 0.03 - - -
Capex / Sales - - - - - -
Announcement Date 30/05/18 06/09/19 07/12/20 08/11/21 08/09/22 09/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
KOBO BIOTECH LIMITED Stock Kobo Biotech Limited
+22.58% 1.14M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+56.60% 819B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.42% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.37% 329B
ABBVIE INC. Stock AbbVie Inc.
+9.48% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.04% 225B
NOVARTIS AG Stock Novartis AG
+13.31% 217B
AMGEN INC. Stock Amgen Inc.
+8.40% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.99% 158B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. KOBO Stock
  4. Financials Kobo Biotech Limited